Top Markets
Coin of the day
Qlife Holding AB (publ) Qlife Holding AB (publ)

Qlife Holding AB (publ)

QLIFE
Clasificación en acciones #36577
Operating as a medical technology firm, Qlife Holding AB (publ) specializes in... Operating as a medical technology firm, Qlife Holding AB (publ) specializes in the production and distribution of in-vitro diagnostic instruments and their associated chemical reagents. Their flagship offering is the Egoo.Health Platform, a comprehensive system comprising a measuring device, single-use test capsules, and integrated software. This innovative platform facilitates the detection of various biomarkers or viral agents, with each capsule tailored for a distinct diagnostic purpose. The range of supported biomarkers encompasses C-reactive protein for home-based monitoring, Phenylalanine (PHE) vital for managing Phenylketonuria (PKU) in patients, and a multiplex test designed to identify Sars-CoV-2 and Influenza, aiding in the detection of viral and bacterial infections. Established in 2019, Qlife's operations are headquartered in Helsingborg, Sweden.
Precio por acción
$0.20529272
Última sincronización: 2026-08-14
Capitalización bursátil
$2.54M
Cambio (1 día)
0.11%
Cambio (1 año)
-49.29%
País
SE
Comercio Qlife Holding AB (publ) (QLIFE)

Categoría

Ratio P/B de Qlife Holding AB (publ) (QLIFE)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Qlife Holding AB (publ), el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Qlife Holding AB (publ) desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
3.7944 -
US
5.423 -
US
2.0146 -
IE
3.072 -
US
4.9725 -
US